Literature DB >> 26577641

DICER1 syndrome can mimic different genetic tumor predispositions.

Yasmin Mehraein1, Irene Schmid2, Marlene Eggert1, Jürgen Kohlhase3, Ortrud K Steinlein4.   

Abstract

DICER1, a RNAse endonuclease involved in the processing of siRNA and microRNA, is known to play a pivotal role in the post-transcriptional regulation of gene expression. Germ line mutations in the DICER1 gene increase the risk for different types of tumors. At present, DICER1 syndrome is an established, though not well defined, member of the group of genetic tumor predisposition syndromes. Here, we report a DICER1 syndrome family with a medical history of different rare tumors mostly occurring at a young age. The tumor spectrum in this family included both DICER1 syndrome-typical forms, such as pleuropulmonary blastoma, multinodular goiter, and cystic nephroma, and not previously reported manifestations, such as pilomatrixoma, and juvenile basal cell carcinoma. The latter tumor types are usually considered to be indicators of familial adenomatous polyposis and basal cell nevus syndrome.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Basal cell carcinoma; Basal cell nevus syndrome; DICER1 syndrome; Familial adenomatous polyposis; Pilomatrixoma; Pleuropulmonary blastoma

Mesh:

Substances:

Year:  2015        PMID: 26577641     DOI: 10.1016/j.canlet.2015.11.002

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

Review 1.  Ultrasound Imaging of Cystic Nephroma.

Authors:  Federico Greco; Eliodoro Faiella; Domiziana Santucci; Delia De Lisi; Gianguido Lo Vullo; Bruno Beomonte Zobel; Rosario Francesco Grasso
Journal:  J Kidney Cancer VHL       Date:  2017-07-20

Review 2.  Regulatory mechanisms of microRNA expression.

Authors:  Lyudmila F Gulyaeva; Nicolay E Kushlinskiy
Journal:  J Transl Med       Date:  2016-05-20       Impact factor: 5.531

Review 3.  DICER1 Syndrome: DICER1 Mutations in Rare Cancers.

Authors:  Jake C Robertson; Cheryl L Jorcyk; Julia Thom Oxford
Journal:  Cancers (Basel)       Date:  2018-05-15       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.